Azelaoyl PAF

• Catalog No.: A6850
• M. F.: C33H66NO9P
• M. W.: 651.852201

SYNONYMS

• IUPAC name: (2-{[(2R)-2-[(8-carboxyoctanoyl)oxy]-3-(hexadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
• IUPAC Traditional name: (2-{[(2R)-2-[(8-carboxyoctanoyl)oxy]-3-(hexadecyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium
• Synonyms: 1-O-Hexadecyl-2-azelaoyl-sn-glycero-3-phosphocholine; hexadecyl azelaoyl phosphatidylcholine; 1-O-Hexadecyl-2-O-(9-carboxyoctanoyl)-sn-glyceryl-3-phosphocholine

DATABASE IDS

• MDL Number: MFCD03412018
• EC Number: 200-578-6

PROPERTIES

• Concentration: 10 mg/mL in ethanol
• Empirical Formula (Hill Notation): C33H66NO9P
• Shipped in: wet ice
• Apperance: liquid
• Flash Point: 14 °C
• Flash Point: 57.2 °F
• GHS Signal Word: Danger
• GHS Hazard statements: H225
• European Hazard Symbols: Flammable (F)
• Personal Protective Equipment: Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
• GHS Precautionary statements: P210
• RID/ADR: UN 1170 3/PG 2
• Risk Statements: 11
• Safety Statements: 7-16
• Storage Temperature: -20°C
• Hazard Class: 3
• UN Number: 1170
• Packing Group: 2
• German water hazard class: 2

DETAILS

Description (English)

Biochem/physiol Actions
Potent PPARγ agonist.
Application
Azelaoyl PAF is a potent PPARγ agonist. Azelaoyl PAF has been used to investigate whether peroxisome proliferator-activated receptors gamma agonists could play a role in the treatment of Friedreich′s ataxia, a neurodegenerative disease due to frataxin deficiency.

Description (简体中文)

Biochem/physiol Actions
Potent PPARγ agonist.
Application
Azelaoyl PAF is a potent PPARγ agonist. Azelaoyl PAF has been used to investigate whether peroxisome proliferator-activated receptors gamma agonists could play a role in the treatment of Friedreich′s ataxia, a neurodegenerative disease due to frataxin deficiency.